1978
DOI: 10.1016/0014-2964(78)90224-4
|View full text |Cite
|
Sign up to set email alerts
|

Quelamycin, a new derivative of adriamycin with several possible therapeutic advantages

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
25
0

Year Published

1985
1985
2011
2011

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 76 publications
(26 citation statements)
references
References 4 publications
1
25
0
Order By: Relevance
“…The early suggestion that an iron-adriamycin complex, quelamycin, ameliorates the cardiac toxicity of adriamycin has not been substantiated in other investigations (77,78). One of the problems with this work was the use of a mixture of iron and Adr with a stoichiometry of Fe3Adr, which does not represent the actual coordination stoichiometry Fe(Adr)2 or Fe(Adr)3 (77).…”
Section: Esr Studies Of Iron Adriamycin Fe(adr)3mentioning
confidence: 97%
See 1 more Smart Citation
“…The early suggestion that an iron-adriamycin complex, quelamycin, ameliorates the cardiac toxicity of adriamycin has not been substantiated in other investigations (77,78). One of the problems with this work was the use of a mixture of iron and Adr with a stoichiometry of Fe3Adr, which does not represent the actual coordination stoichiometry Fe(Adr)2 or Fe(Adr)3 (77).…”
Section: Esr Studies Of Iron Adriamycin Fe(adr)3mentioning
confidence: 97%
“…One of the problems with this work was the use of a mixture of iron and Adr with a stoichiometry of Fe3Adr, which does not represent the actual coordination stoichiometry Fe(Adr)2 or Fe(Adr)3 (77). Recently, an iron adriamycin complex that has been difficult to characterize has been shown to bind to erythrocyte ghost membranes and is involved in lipid peroxidation (79).…”
Section: Esr Studies Of Iron Adriamycin Fe(adr)3mentioning
confidence: 99%
“…The dose of doxorubicin (8 mg/kg of body weight) that we applied was relatively high, corresponding to 80% of the lethal dose (LD50) for intravenous administration in rats (18) and 55%-80% of the lethal dose (LD50) for intraperitoneal administration in mice (19,20). The transient decline of body weight of rats that we observed after a single intraperitoneal dose of doxorubicin was also noticed in other studies (21) and was apparently related to a temporary reduction of food intake.…”
Section: Discussionmentioning
confidence: 99%
“…It is well known that the co-encapsulation of metal-ligand complexes has enabled the release of several drugs in synergistic ratios to maximize antidisease activity and minimize toxicity and this has been used in the clinic. [16] Recently, it has been shown that the combination of high and regular porosity with the presence of organic groups within the metal-organic framework combines the advantages of both to achieve a high drug loading and a controlled release. [17] Pt-ligand coordination bonding combined with the nanoscale coordination of polymers with amorphous silica shells has been used to effectively control the release of a drug.…”
Section: Introductionmentioning
confidence: 99%